Beijing, China

Le Li

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Le Li

Introduction

Le Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of technology and medicine, holding a total of 5 patents. His work focuses on developing innovative solutions that address various challenges in health and technology.

Latest Patents

One of Le Li's latest patents is titled "Interleukin-13 binding cyclic oligopeptides and methods of use thereof." This patent relates to cyclic oligopeptides that bind to interleukin-13 (IL-13), which are therapeutically useful in treating or preventing IL-13-associated skin disorders or conditions. The patent also outlines methods for producing these IL-13-binding cyclic oligopeptides. Another notable patent is for a "Touch pad and method for manufacturing the same, touch display device." This invention includes a touch pad with a first conductive pattern layer and a second conductive pattern layer, designed to enhance the functionality of touch display devices.

Career Highlights

Le Li has worked with several notable companies, including Hefei Xinsheng Optoelectronics Technology Co., Ltd. and BOE Technology Group Co., Ltd. His experience in these organizations has contributed to his expertise in developing cutting-edge technologies.

Collaborations

Throughout his career, Le Li has collaborated with talented individuals such as Bisheng Li and Baoran Li. These collaborations have fostered innovation and have led to the successful development of various projects.

Conclusion

Le Li's contributions to technology and medicine through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treating health conditions and enhancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…